NGSベースRNA-seqの世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global NGS-based RNA-seq Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-00751 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、NGSベースRNA-seqの世界市場を広く調査・分析し、今後の市場展望をまとめております。NGSベースRNA-seqの種類別市場規模（SBS、SMRT）、用途別市場規模（トランスクリプトームエピジェネティクス、スモール RNA）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Illumina、Perkinelmer、Qaigen、Thermo Fisher Scientific、Oxford Nanopore Technologies、Pacific Biosciences Of California、Gatc Biotech、Agilent Technologies、F. Hoffmann-La Roche、Eurofins Scientific、Macrogen ・地域別グローバル市場分析 2015年-2020年 ・NGSベースRNA-seqの北米市場（アメリカ、カナダ、メキシコ） ・NGSベースRNA-seqのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・NGSベースRNA-seqのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・NGSベースRNA-seqの南米市場（ブラジル、アルゼンチン） ・NGSベースRNA-seqの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：SBS、SMRT ・用途別分析：トランスクリプトームエピジェネティクス、スモール RNA ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global NGS-based RNA-seq market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 2189.5 million by 2025, from USD 1450 million in 2019.

The NGS-based RNA-seq market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
NGS-based RNA-seq market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, NGS-based RNA-seq market has been segmented into:
SBS
SMRT

By Application, NGS-based RNA-seq has been segmented into:
Transcriptome Epigenetics
Small RNA

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global NGS-based RNA-seq market presented in the report. This section sheds light on the sales growth of different regional and country-level NGS-based RNA-seq markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global NGS-based RNA-seq market.

The report offers in-depth assessment of the growth and other aspects of the NGS-based RNA-seq market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and NGS-based RNA-seq Market Share Analysis
NGS-based RNA-seq competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, NGS-based RNA-seq sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the NGS-based RNA-seq sales, revenue and market share for each player covered in this report.

The major players covered in NGS-based RNA-seq are:
Illumina
Perkinelmer
Qaigen
Thermo Fisher Scientific
Oxford Nanopore Technologies
Pacific Biosciences Of California
Gatc Biotech
Agilent Technologies
F. Hoffmann-La Roche
Eurofins Scientific
Macrogen

レポート目次

---

Table of Contents

1 NGS-based RNA-seq Market Overview
1.1 Product Overview and Scope of NGS-based RNA-seq
1.2 Classification of NGS-based RNA-seq by Type
1.2.1 Global NGS-based RNA-seq Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global NGS-based RNA-seq Revenue Market Share by Type in 2019
1.2.3 SBS
1.2.4 SMRT
1.3 Global NGS-based RNA-seq Market by Application
1.3.1 Overview: Global NGS-based RNA-seq Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Transcriptome Epigenetics
1.3.3 Small RNA
1.4 Global NGS-based RNA-seq Market by Regions
1.4.1 Global NGS-based RNA-seq Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of NGS-based RNA-seq (2015-2025)
1.4.3 North America (USA, Canada and Mexico) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) NGS-based RNA-seq Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) NGS-based RNA-seq Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.2 Perkinelmer
2.2.1 Perkinelmer Details
2.2.2 Perkinelmer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Perkinelmer SWOT Analysis
2.2.4 Perkinelmer Product and Services
2.2.5 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.3 Qaigen
2.3.1 Qaigen Details
2.3.2 Qaigen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Qaigen SWOT Analysis
2.3.4 Qaigen Product and Services
2.3.5 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Oxford Nanopore Technologies SWOT Analysis
2.5.4 Oxford Nanopore Technologies Product and Services
2.5.5 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pacific Biosciences Of California SWOT Analysis
2.6.4 Pacific Biosciences Of California Product and Services
2.6.5 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gatc Biotech
2.7.1 Gatc Biotech Details
2.7.2 Gatc Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gatc Biotech SWOT Analysis
2.7.4 Gatc Biotech Product and Services
2.7.5 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Agilent Technologies SWOT Analysis
2.8.4 Agilent Technologies Product and Services
2.8.5 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 F. Hoffmann-La Roche SWOT Analysis
2.9.4 F. Hoffmann-La Roche Product and Services
2.9.5 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eurofins Scientific
2.10.1 Eurofins Scientific Details
2.10.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eurofins Scientific SWOT Analysis
2.10.4 Eurofins Scientific Product and Services
2.10.5 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
2.11 Macrogen
2.11.1 Macrogen Details
2.11.2 Macrogen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Macrogen SWOT Analysis
2.11.4 Macrogen Product and Services
2.11.5 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global NGS-based RNA-seq Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 NGS-based RNA-seq Players Market Share
3.2.2 Top 10 NGS-based RNA-seq Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global NGS-based RNA-seq Revenue and Market Share by Regions
4.2 North America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.3 Europe NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.5 South America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5 North America NGS-based RNA-seq Revenue by Countries
5.1 North America NGS-based RNA-seq Revenue by Countries (2015-2020)
5.2 USA NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5.3 Canada NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
5.4 Mexico NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6 Europe NGS-based RNA-seq Revenue by Countries
6.1 Europe NGS-based RNA-seq Revenue by Countries (2015-2020)
6.2 Germany NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.3 UK NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.4 France NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.5 Russia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
6.6 Italy NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7 Asia-Pacific NGS-based RNA-seq Revenue by Countries
7.1 Asia-Pacific NGS-based RNA-seq Revenue by Countries (2015-2020)
7.2 China NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.3 Japan NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.4 Korea NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.5 India NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
8 South America NGS-based RNA-seq Revenue by Countries
8.1 South America NGS-based RNA-seq Revenue by Countries (2015-2020)
8.2 Brazil NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
8.3 Argentina NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue NGS-based RNA-seq by Countries
9.1 Middle East & Africa NGS-based RNA-seq Revenue by Countries (2015-2020)
9.2 Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.3 UAE NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.4 Egypt NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
9.5 South Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global NGS-based RNA-seq Revenue and Market Share by Type (2015-2020)
10.2 Global NGS-based RNA-seq Market Forecast by Type (2019-2024)
10.3 SBS Revenue Growth Rate (2015-2025)
10.4 SMRT Revenue Growth Rate (2015-2025)
11 Global NGS-based RNA-seq Market Segment by Application
11.1 Global NGS-based RNA-seq Revenue Market Share by Application (2015-2020)
11.2 NGS-based RNA-seq Market Forecast by Application (2019-2024)
11.3 Transcriptome Epigenetics Revenue Growth (2015-2020)
11.4 Small RNA Revenue Growth (2015-2020)
12 Global NGS-based RNA-seq Market Size Forecast (2021-2025)
12.1 Global NGS-based RNA-seq Market Size Forecast (2021-2025)
12.2 Global NGS-based RNA-seq Market Forecast by Regions (2021-2025)
12.3 North America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.4 Europe NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.6 South America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa NGS-based RNA-seq Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global NGS-based RNA-seq Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of NGS-based RNA-seq by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global NGS-based RNA-seq Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market NGS-based RNA-seq Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Illumina Corporate Information, Location and Competitors
Table 6. Illumina NGS-based RNA-seq Major Business
Table 7. Illumina NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 8. Illumina SWOT Analysis
Table 9. Illumina NGS-based RNA-seq Product and Solutions
Table 10. Illumina NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Perkinelmer Corporate Information, Location and Competitors
Table 12. Perkinelmer NGS-based RNA-seq Major Business
Table 13. Perkinelmer NGS-based RNA-seq Total Revenue (USD Million) (2018-2019)
Table 14. Perkinelmer SWOT Analysis
Table 15. Perkinelmer NGS-based RNA-seq Product and Solutions
Table 16. Perkinelmer NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Qaigen Corporate Information, Location and Competitors
Table 18. Qaigen NGS-based RNA-seq Major Business
Table 19. Qaigen NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 20. Qaigen SWOT Analysis
Table 21. Qaigen NGS-based RNA-seq Product and Solutions
Table 22. Qaigen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific NGS-based RNA-seq Major Business
Table 25. Thermo Fisher Scientific NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific NGS-based RNA-seq Product and Solutions
Table 28. Thermo Fisher Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Oxford Nanopore Technologies Corporate Information, Location and Competitors
Table 30. Oxford Nanopore Technologies NGS-based RNA-seq Major Business
Table 31. Oxford Nanopore Technologies NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 32. Oxford Nanopore Technologies SWOT Analysis
Table 33. Oxford Nanopore Technologies NGS-based RNA-seq Product and Solutions
Table 34. Oxford Nanopore Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pacific Biosciences Of California Corporate Information, Location and Competitors
Table 36. Pacific Biosciences Of California NGS-based RNA-seq Major Business
Table 37. Pacific Biosciences Of California NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 38. Pacific Biosciences Of California SWOT Analysis
Table 39. Pacific Biosciences Of California NGS-based RNA-seq Product and Solutions
Table 40. Pacific Biosciences Of California NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Gatc Biotech Corporate Information, Location and Competitors
Table 42. Gatc Biotech NGS-based RNA-seq Major Business
Table 43. Gatc Biotech NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 44. Gatc Biotech SWOT Analysis
Table 45. Gatc Biotech NGS-based RNA-seq Product and Solutions
Table 46. Gatc Biotech NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Agilent Technologies Corporate Information, Location and Competitors
Table 48. Agilent Technologies NGS-based RNA-seq Major Business
Table 49. Agilent Technologies NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 50. Agilent Technologies SWOT Analysis
Table 51. Agilent Technologies NGS-based RNA-seq Product and Solutions
Table 52. Agilent Technologies NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 54. F. Hoffmann-La Roche NGS-based RNA-seq Major Business
Table 55. F. Hoffmann-La Roche NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 56. F. Hoffmann-La Roche SWOT Analysis
Table 57. F. Hoffmann-La Roche NGS-based RNA-seq Product and Solutions
Table 58. F. Hoffmann-La Roche NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Eurofins Scientific Corporate Information, Location and Competitors
Table 60. Eurofins Scientific NGS-based RNA-seq Major Business
Table 61. Eurofins Scientific NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 62. Eurofins Scientific SWOT Analysis
Table 63. Eurofins Scientific NGS-based RNA-seq Product and Solutions
Table 64. Eurofins Scientific NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Macrogen Corporate Information, Location and Competitors
Table 66. Macrogen NGS-based RNA-seq Major Business
Table 67. Macrogen NGS-based RNA-seq Total Revenue (USD Million) (2017-2018)
Table 68. Macrogen SWOT Analysis
Table 69. Macrogen NGS-based RNA-seq Product and Solutions
Table 70. Macrogen NGS-based RNA-seq Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global NGS-based RNA-seq Revenue (Million USD) by Players (2015-2020)
Table 72. Global NGS-based RNA-seq Revenue Share by Players (2015-2020)
Table 73. Global NGS-based RNA-seq Revenue (Million USD) by Regions (2015-2020)
Table 74. Global NGS-based RNA-seq Revenue Market Share by Regions (2015-2020)
Table 75. North America NGS-based RNA-seq Revenue by Countries (2015-2020)
Table 76. North America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 77. Europe NGS-based RNA-seq Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific NGS-based RNA-seq Revenue (Million USD) by Countries (2015-2020)
Table 79. South America NGS-based RNA-seq Revenue by Countries (2015-2020)
Table 80. South America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa NGS-based RNA-seq Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Table 83. Global NGS-based RNA-seq Revenue (Million USD) by Type (2015-2020)
Table 84. Global NGS-based RNA-seq Revenue Share by Type (2015-2020)
Table 85. Global NGS-based RNA-seq Revenue Forecast by Type (2021-2025)
Table 86. Global NGS-based RNA-seq Revenue by Application (2015-2020)
Table 87. Global NGS-based RNA-seq Revenue Share by Application (2015-2020)
Table 88. Global NGS-based RNA-seq Revenue Forecast by Application (2021-2025)
Table 89. Global NGS-based RNA-seq Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. NGS-based RNA-seq Picture
Figure 2. Global NGS-based RNA-seq Revenue Market Share by Type in 2019
Figure 3. SBS Picture
Figure 4. SMRT Picture
Figure 5. NGS-based RNA-seq Revenue Market Share by Application in 2019
Figure 6. Transcriptome Epigenetics Picture
Figure 7. Small RNA Picture
Figure 8. Global NGS-based RNA-seq Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global NGS-based RNA-seq Revenue Share by Players in 2019
Figure 16. Global Top 5 Players NGS-based RNA-seq Revenue Market Share in 2019
Figure 17. Global Top 10 Players NGS-based RNA-seq Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global NGS-based RNA-seq Revenue Market Share by Regions (2015-2020)
Figure 21. Global NGS-based RNA-seq Revenue Market Share by Regions in 2018
Figure 22. North America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 23. Europe NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 25. South America NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 27. North America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 28. North America NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 29. USA NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 30. Canada NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 31. Mexico NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 32. Europe NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 33. Europe NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 34. Germany NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 35. UK NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 36. France NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 37. Russia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 38. Italy NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 41. China NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 42. Japan NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 43. Korea NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 44. India NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 46. South America NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 47. South America NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 48. Brazil NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 49. Argentina NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa NGS-based RNA-seq Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 53. UAE NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 54. Egypt NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 55. South Africa NGS-based RNA-seq Revenue and Growth Rate (2015-2020)
Figure 56. Global NGS-based RNA-seq Revenue Share by Type (2015-2020)
Figure 57. Global NGS-based RNA-seq Revenue Share by Type in 2019
Figure 58. Global NGS-based RNA-seq Market Share Forecast by Type (2021-2025)
Figure 59. Global SBS Revenue Growth Rate (2015-2020)
Figure 60. Global SMRT Revenue Growth Rate (2015-2020)
Figure 61. Global NGS-based RNA-seq Revenue Share by Application (2015-2020)
Figure 62. Global NGS-based RNA-seq Revenue Share by Application in 2019
Figure 63. Global NGS-based RNA-seq Market Share Forecast by Application (2021-2025)
Figure 64. Global Transcriptome Epigenetics Revenue Growth Rate (2015-2020)
Figure 65. Global Small RNA Revenue Growth Rate (2015-2020)
Figure 66. Global NGS-based RNA-seq Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global NGS-based RNA-seq Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global NGS-based RNA-seq Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 70. Europe NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 72. South America NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa NGS-based RNA-seq Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---